According to Jindan Technology's announcement, the cumulative deviation value of the company's stock closing price increase exceeded 30% for three consecutive trading days on September 17, September 18, and September 21, 2026, which is an abnormal fluctuation in stock trading. After verification, the company's current business situation is normal, there have been no major changes in the internal and external business environment. The company, controlling shareholders and actual controllers have no important matters that should be disclosed but not disclosed, and there were no acts of controlling shareholders, actual controllers, and their co-actors trading the company's shares during the period of change. The company's new polylactic acid biodegradable material project with an annual output of 75,000 tons is still in the trial stage. There is uncertainty about the timing of commissioning and capacity release, and no polylactic acid-related orders have been received. As of September 18, 2026, the company's rolling price-earnings ratio was 68.74 times, which is 23.96 times higher than the rolling price-earnings ratio of the industry to which it belongs. Investors are kindly requested to invest rationally and pay attention to risks.

According to Jindan Technology's announcement, the cumulative deviation value of the company's stock closing price increase exceeded 30% for three consecutive trading days on September 17, September 18, and September 21, 2026, which is an abnormal fluctuation in stock trading. After verification, the company's current business situation is normal, there have been no major changes in the internal and external business environment. The company, controlling shareholders and actual controllers have no important matters that should be disclosed but not disclosed, and there were no acts of controlling shareholders, actual controllers, and their co-actors trading the company's shares during the period of change. The company's new polylactic acid biodegradable material project with an annual output of 75,000 tons is still in the trial stage. There is uncertainty about the timing of commissioning and capacity release, and no polylactic acid-related orders have been received. As of September 18, 2026, the company's rolling price-earnings ratio was 68.74 times, which is 23.96 times higher than the rolling price-earnings ratio of the industry to which it belongs. Investors are kindly requested to invest rationally and pay attention to risks.